I will reserve my opinion on AHI for risk of being...

I will reserve my opinion on AHI for risk of being moderated.....IMO there's nothing innovative or new in what they are doing, it's hardly groundbreaking or unique technology and the way I see it its a competitive space. Its very hard to find direct peers in the small tech space which is entirely different to the plethora of comparables both in psychedelics and cannabinoids that IHL can be benchmarked to.

Roth's past 3 deals in Australia have been PLL, LKE and IMU and I and others have posted about those before, see link below:

https://hotcopper.com.au/posts/55375033/single

It comes down to the product and I for one believe that the unique offering of IHL will see an oversubscribed US IPO and results more along the lines of previous Roth transactions.

Ted.